Literature DB >> 30908107

Clinical considerations for oral beta-lactams as step-down therapy for Enterobacteriaceae bloodstream infections.

Bryan T Mogle1, Mario V Beccari1, Jeffrey M Steele1,2, Tasaduq Fazili2, Wesley D Kufel1,2,3.   

Abstract

Entities:  

Keywords:  Enterobacteriaceae; Gram-negative; Oral beta-lactam; bacteremia; bloodstream infections; pharmacodynamics; pharmacokinetics

Year:  2019        PMID： 30908107     DOI： 10.1080/14656566.2019.1594774

Source DB:  PubMed          Journal:  Expert Opin Pharmacother        ISSN： 1465-6566            Impact factor:   3.889


× No keyword cloud information.
  5 in total

1.  Early oral stepdown antibiotic therapy versus continuing intravenous therapy for uncomplicated Gram-negative bacteraemia (the INVEST trial): study protocol for a multicentre, randomised controlled, open-label, phase III, non-inferiority trial.

Authors:  I Russel Lee; Steven Y C Tong; Joshua S Davis; David L Paterson; Sharifah F Syed-Omar; Kwong Ran Peck; Doo Ryeon Chung; Graham S Cooke; Eshele Anak Libau; Siti-Nabilah B A Rahman; Mihir P Gandhi; Luming Shi; Shuwei Zheng; Jenna Chaung; Seow Yen Tan; Shirin Kalimuddin; Sophia Archuleta; David C Lye
Journal:  Trials       Date:  2022-07-19       Impact factor: 2.728

2.  Oral Fluoroquinolone or Trimethoprim-sulfamethoxazole vs. ß-lactams as Step-Down Therapy for Enterobacteriaceae Bacteremia: Systematic Review and Meta-analysis.

Authors:  Chitra Punjabi; Vivian Tien; Lina Meng; Stan Deresinski; Marisa Holubar
Journal:  Open Forum Infect Dis       Date:  2019-08-14       Impact factor: 3.835

3.  Oral β-Lactam Antibiotics vs Fluoroquinolones or Trimethoprim-Sulfamethoxazole for Definitive Treatment of Enterobacterales Bacteremia From a Urine Source.

Authors:  Jesse D Sutton; Vanessa W Stevens; Nai-Chung N Chang; Karim Khader; Tristan T Timbrook; Emily S Spivak
Journal:  JAMA Netw Open       Date:  2020-10-01

4.  Epidemiology of Complicated Urinary Tract Infections due to Enterobacterales Among Adult Patients Presenting in Emergency Departments Across the United States.

Authors:  Thomas P Lodise; Teena Chopra; Brian H Nathanson; Katherine Sulham; Mauricio Rodriguez
Journal:  Open Forum Infect Dis       Date:  2022-06-24       Impact factor: 4.423

5.  Strongly Bactericidal All-Oral β-Lactam Combinations for the Treatment of Mycobacterium abscessus Lung Disease.

Authors:  Dereje A Negatu; Matthew D Zimmerman; Véronique Dartois; Thomas Dick
Journal:  Antimicrob Agents Chemother       Date:  2022-09-01       Impact factor: 5.938
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.